Table 2.
The prevalence of Mycoplasma genitalium in female samples, by sample type and study site
| Sample type | Urine | Vaginal swab | Endocervical swab | Rectal swab | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Study site | Germany (AME) | Belgium (CMA) | Germany (AME) | Wales (PHW) |
Spain (USC) |
Wales (PHW) |
Spain (USC) |
||||||
| Clinic type | NA | Primary care | NA | Primary care | STI clinic | Other | Overall | Primary care | STI clinic | Other | Overall | STI clinic | STI clinic |
| Prevalence, % (n/N) | 1.7% (5/300) | 1.7% (4/238) | 6.7% (1/15) | 1.6% (1/62) | 7.3% (15/206) | 4.1% (2/49) | 5.7% (18/317) | 2.5% (4/161) | 2.2% (2/89) | 3.7% (2/54) | 2.6% (8/304) | 6.1% (5/82) | 0.0% (0/4) |
| 95% CI | (0.7%, 3.8%) | (0.7%, 4.2%) | (1.2%, 29.8%) | (0.3%, 8.6%) | (4.5%, 11.7%) | (1.1%, 13.7%) | (3.6%, 8.8%) | (1.0%, 6.2%) | (0.6%, 7.8%) | (1.0%, 12.5%) | (1.3%, 5.1%) | (2.6%, 13.5%) | (0.0%, 49.0%) |
| Overall prevalence, a % (n/N) | 1.7% (9/538) | 5.7% (19/332) | 2.6% (8/304) | 5.8% (5/86) | |||||||||
| 95% CI | (0.9%, 3.1%) | (3.7%, 8.8%) | (1.3%, 5.15%) | (2.5%, 12.9%) | |||||||||
AME, Amedes; CI, confidence interval; CMA, Centrum voor Medische Analyse; NA, not available; PHW, Public Health Wales, UK; STI, sexually transmitted infection; USC, Hospital Universitario San Cecilio
aOverall prevalence includes samples with missing data on symptom status